<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/3CFB9490-9508-4E43-A019-042327F992A7"><gtr:id>3CFB9490-9508-4E43-A019-042327F992A7</gtr:id><gtr:name>Eisai Ltd</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>SLMS Research Support Centre</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3CFB9490-9508-4E43-A019-042327F992A7"><gtr:id>3CFB9490-9508-4E43-A019-042327F992A7</gtr:id><gtr:name>Eisai Ltd</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/F89B2461-11DD-4E45-84EE-D5780979AFD9"><gtr:id>F89B2461-11DD-4E45-84EE-D5780979AFD9</gtr:id><gtr:firstName>Alan</gtr:firstName><gtr:otherNames>James</gtr:otherNames><gtr:surname>Thompson</gtr:surname><gtr:orcidId>0000-0002-4333-8496</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0802652"><gtr:id>2364EB0E-A1A3-47B6-814E-E50B78C2FC1B</gtr:id><gtr:title>DPFS Resource Request University College London</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0802652</gtr:grantReference><gtr:abstractText>Funding agencies continue to invest in basic science and this needs to be balanced with investment that leads directly to patient benefit. MRC?s DPFS initiative is therefore timely and forms an integrated approach with the MRC Translational Funding initiative. This application is for underpinning resource to support UCL?s portfolio of DPFS studies. This will be in the form of staff who will provide research project management support to accelerate the translation of fundamental research ideas into tangible patient benefit. We envisage that UCL will develop an expanding portfolio of DPFS projects supported by the MRC. These will aim to develop new drugs, medical devices and diagnostics in areas of unmet clinical need (including diabetes, heart and brain disease, and infection) that affect the ageing population. We request support for two research project managers to co-ordinate these programmes, work closely with and draw upon a pool of consultants as needed and as our portfolio develops, to manage the entire developmental pathway.</gtr:abstractText><gtr:technicalSummary>The major investment by funding agencies in basic science in recent years needs to be matched by translational funding for projects that will turn basic discoveries into clinical benefit. The DPFS initiative is therefore timely and forms an integrated approach with the MRC Translational pump-priming initiative. This application is for underpinning resources to support UCL?s portfolio of DPFS studies. We are requesting staff resources to provide the necessary research project management support for what is envisaged will be a large portfolio of DPFS projects supported by the MRC. The 10 individual DPFS outline proposals submitted in this first funding round cover three areas within UCL?s translational research activities (therapeutics, diagnostics and devices) and fall within areas of clinical strength across UCL and UCLH (?diabetes, cardiovascular disease and its sequelae?, ?infection?, ?neurodegerative disorders?, ?hepatology and gastroenterology?, and ?hearing and sight?). Most of the proposals submitted in the current round address interventions that are convergent with UCL?s translational strategy - ?lifelong health, capability and wellbeing? - and target disorders associated with the ageing population. We request two research project managers who will work closely with and draw upon a pool of consultants as needed and as the DPFS portfolio develops, to manage the entire developmental pathway. A group of advisors internal and external to UCL will be called upon to advise as the projects develop.</gtr:technicalSummary><gtr:fund><gtr:end>2012-01-07</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-06-08</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>422611</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Eisai Ltd</gtr:collaboratingOrganisation><gtr:country>Japan</gtr:country><gtr:description>UCL-Eisai-Therapeutic Innovation Group</gtr:description><gtr:id>612DE0EE-01CB-4D97-844C-A8FC3FAF38EB</gtr:id><gtr:impact>New research strategies</gtr:impact><gtr:partnerContribution>partnership in driving UCL biomedical research towards patient benefit in the field of neurodegeneration</gtr:partnerContribution><gtr:piContribution>Academic leadership of joint collaborative partnership with Eisai Pharmaceuticals. The Therapeutic Innovation Group provides collaboration on pharmaceutical research to investigate radical new ways of treating neurological diseases such as Alzheimer's, Parkinson's and related disorders, identifying and validating novel drug targets, developing new therapeutics and evaluating them in proof-of-concept clinical trials</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>School Project</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>B2DAA1B5-1D0F-4484-8AD9-054084C13C82</gtr:id><gtr:impact>Microbiology talk, initiated discussion around microbes in the environment, health and on the body

First talk led to Royal Society grant application; Children continued to make observations of microbes on food and in environment some weeks later.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1250000</gtr:amountPounds><gtr:country>Japan</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Eisai Inc</gtr:description><gtr:fundingOrg>Eisai Ltd</gtr:fundingOrg><gtr:id>BADF59F6-896D-42E3-A3D9-BE63D35553DC</gtr:id><gtr:sector>Private</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>700000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Confidence in Concept</gtr:description><gtr:end>2015-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MC_PC_13078</gtr:fundingRef><gtr:id>843E836A-ED86-4202-80CD-CCE6C4921FE9</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>784000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Confidence in Concept Fund</gtr:description><gtr:end>2019-02-02</gtr:end><gtr:fundingOrg>MRC-UK</gtr:fundingOrg><gtr:fundingRef>MC_PC_16063</gtr:fundingRef><gtr:id>F5AFF4DE-D1DE-46F7-9F38-203F598C1070</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2017-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>700000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>MRC Research Grant</gtr:department><gtr:description>confidence in concept</gtr:description><gtr:end>2016-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MC_PC_14118 v.2</gtr:fundingRef><gtr:id>06FDD0A9-93EA-49EE-9918-A50842FD2048</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2015-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>700000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Confidence in Concept Scheme</gtr:description><gtr:end>2013-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MC_PC_12024</gtr:fundingRef><gtr:id>8C7004C0-45AC-4F01-B2B7-F718F137A475</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>700000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Confidence in Concept</gtr:description><gtr:end>2017-07-02</gtr:end><gtr:fundingOrg>MRC-UK</gtr:fundingOrg><gtr:id>CE91D542-86AF-4B3F-84B0-368E2DF4BF78</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2016-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>23000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>WT Institutional Strategic Support Fund 'Investing in Excellent Researchers'</gtr:description><gtr:end>2015-08-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:fundingRef>097815/Z/11/Z</gtr:fundingRef><gtr:id>7ADD4417-4259-4854-82EA-01C0E315C9D1</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have created a user friendly database to capture and track the research projects with translational potential within UCL</gtr:description><gtr:id>FE849C28-1485-4F4E-ADF4-0C582678DE4C</gtr:id><gtr:impact>This database will enable us to capture new projects, track the progress of existing projects and also to start new collaborations between the groups (please see collaborations tab for examples). Additionally, interrogation of the database allows the identification of funding gaps, strengths &amp;amp; weaknesses of areas of investigation key to UCL.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>translational research database</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">G0802652</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>5191BE6E-A234-4D62-A4F3-B50DBAAE8217</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>4.5  Resources and infrastructure (detection)</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>A056411B-DD7A-4062-BE33-7849FBC9BFA7</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>5.9  Resources and infrastructure (development of treatments)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>